These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin. Fraser HM, Nestor JJ, Vickery BH. Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885 [Abstract] [Full Text] [Related]
11. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach. Lemay A, Faure N. J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711 [Abstract] [Full Text] [Related]
12. Inhibition of progesterone secretion during the luteal phase by two luteinizing hormone-releasing hormone agonists in Macaca fascicularis. Raynaud JP, Mary I, Moguilewsky M, Mouren M, Labrie F. Fertil Steril; 1980 Dec; 34(6):593-8. PubMed ID: 6778718 [Abstract] [Full Text] [Related]
15. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle. Garzo VG, Liu J, Ulmann A, Baulieu E, Yen SS. J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438 [Abstract] [Full Text] [Related]